Adjuvant Therapy of Testis Cancer: The Role of Vinblastine and Bleomycin
- 1 September 1980
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 124 (3) , 369-371
- https://doi.org/10.1016/s0022-5347(17)55453-1
Abstract
Patients (37) with testis cancer who received adjuvant chemotherapy with vinblastine and bleomycin were studied. These patients included 5 with stage III disease who were down-staged by a surgical procedure and 32 with stage II disease. Of the 32 patients, 26 had stage IIB tumors showing gross nodal disease. There have been 4 deaths, 2 of disease and 2 as a result of therapy. The remaining patients are free of disease. The estimated 5 yr survival is 85%.This publication has 5 references indexed in Scilit:
- COMBINATION CHEMOTHERAPY WITH CIS-DIAMMINE-DICHLORO-PLATINUM, VINBLASTINE, AND BLEOMYCIN IN ADVANCED TESTICULAR NON-SEMINOMAThe Lancet, 1979
- Chemotherapy for Disseminated Testicular CancerUrologic Clinics of North America, 1977
- Rationale for combined therapyCancer, 1977
- Combination chemotherapy in germinal cell tumorsCancer Treatment Reviews, 1976
- SUPERVOLTAGE RADIATION THERAPY OF THE TESTICULAR TUMORSAmerican Journal of Roentgenology, 1973